XML 67 R45.htm IDEA: XBRL DOCUMENT v3.24.0.1
Collaborative Agreements (Details) - USD ($)
 1 Months Ended 12 Months Ended
Jan. 31, 2022
Jun. 30, 2020
Apr. 30, 2020
Jan. 31, 2020
Aug. 30, 2019
Oct. 31, 2018
Apr. 30, 2018
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Revenue from collaborative arrangements and other contracts, including affiliated entity               $ 832,010 $ 10,262,268 $ 1,774,758
ApolloBio Corporation | Collaborative Arrangement                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Upfront payment received               3,600,000 1,200,000 4,500,000
ApolloBio | Collaborative Arrangement                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Additional revenue to be achieved               $ 20,000,000    
Obligation period to pay royalties               10 years    
Funding received               $ 245,000    
Revenue from collaborative arrangements and other contracts, including affiliated entity                 0 0
Coalition for Epidemic Preparedness Innovations | Collaborative Arrangement                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Upfront payment received               1,800,000 6,700,000 10,000,000
Collaborative agreement, funding to be received     $ 6,900,000              
Coalition for Epidemic Preparedness Innovations | Collaborative Arrangement | Lassa Fever And MERS Vaccine                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Collaborative agreement, funding to be received             $ 56,000,000      
Collaborative agreement, period to receive funding for research and development             5 years      
Accounts receivable               0 1,700,000  
Accrued Liabilities               2,200,000 0  
Coalition for Epidemic Preparedness Innovations | Collaborative Arrangement | COVID19 Vaccine                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Collaborative agreement, funding to be received       $ 9,000,000       330,000 1,100,000 6,900,000
Accrued Liabilities               2,100,000    
Grants receivable                 2,300,000  
Coalition for Epidemic Preparedness Innovations | Collaborative Arrangement | CELLECTRA 3PSP Proprietary Smart Device                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Collaborative agreement, funding to be received     5,000,000              
Coalition for Epidemic Preparedness Innovations | Collaborative Arrangement | IN O4800                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Collaborative agreement, funding to be received     $ 1,300,000              
Bill And Melinda Gates Foundation | Collaborative Arrangement | D N A Encoded Monoclonal Antibody Technology                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Collaborative agreement, funding to be received         $ 1,100,000 $ 2,200,000   70,000 233,000 182,000
Grants receivable               87,000 153,000  
Department Of Defence | Collaborative Arrangement                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Grant proceeds received               0 6,100,000 27,100,000
Procurement contract               $ 0 $ 9,600,000 $ 755,000
Department Of Defence | Collaborative Arrangement | CELLECTRA 3PSP Proprietary Smart Device                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Funding received   $ 54,500,000                
Purchase price, procurement contract $ 10,700,000 $ 16,800,000